Related Experiment Videos
[Microscopic polyangiitis]
1Service de Néphrologie B et INSERM U489, Hôpital Tenon, Assistance Publique-Hôpitaux de Paris et Université Paris VI, 4, rue de la Chine, 75020 Paris, France.
Abstract:
Microscopic polyangiitis is a non-granulomatous necrotizing vasculitis involving small vessels. Clinical manifestations are highly polymorphic, but rapidly progressive glomerulonephritis is one of the most frequent and most severe manifestations of the disease. Biopsy of an affected organ and detection of circulating anti-neutrophil cytoplasmic antibodies (ANCA) are key elements for the positive diagnosis of microscopic polyangiitis. Biopsies can disclose necrotizing vasculitis affecting small vessels, without granulomas and without immune deposits. ANCA are very specific for microscopic polyangiitis, Wegener's granulomatosis and Churg-Strauss syndrome when they are positive by indirect immunofluorescence and are directed against myeloperoxidase or proteinase 3. Such ANCA are found in about 70% of patients with microscopic polyangiitis. Treatment of severe forms of microscopic polyangiitis is based on the administration of pulse methylprednisolone, oral corticosteroids and cyclophosphamide. In the mildest forms of the disease, one can probably try either to competely avoid using immunosuppressive drugs, or to replace cyclophosphamide with azathioprine. Treatment induces a complete remission of the disease in more than 90% of cases, but about 30% of the patients will experience a relapse, and progressive worsening of renal function can occur in patients with severe chronic renal failure.
Insights
Microscopic polyangiitis is a small vessel vasculitis often causing severe glomerulonephritis. Diagnosis relies on biopsy and anti-neutrophil cytoplasmic antibodies (ANCA), with treatment achieving high remission rates.
Area of Science:
- Nephrology
- Rheumatology
- Immunology
Context:
- Microscopic polyangiitis (MPA) is a non-granulomatous necrotizing vasculitis affecting small blood vessels.
- Rapidly progressive glomerulonephritis is a common and severe manifestation of MPA.
- Diagnosis requires organ biopsy and detection of anti-neutrophil cytoplasmic antibodies (ANCA).
Purpose:
- To outline the diagnostic criteria and treatment strategies for microscopic polyangiitis.
- To highlight the role of ANCA testing in diagnosing MPA and related vasculitides.
- To discuss treatment outcomes, including remission rates and potential for relapse.
Summary:
- MPA presents with diverse clinical features, notably severe glomerulonephritis.
- Diagnostic hallmarks include necrotizing vasculitis on biopsy and specific ANCA positivity (targeting myeloperoxidase or proteinase 3).
- Treatment for severe MPA involves corticosteroids and cyclophosphamide, achieving >90% remission, though relapses occur in ~30%.
Impact:
- Establishes diagnostic standards for microscopic polyangiitis.
- Provides evidence-based treatment guidelines for MPA management.
- Informs prognosis and long-term patient monitoring, especially for renal function preservation.